DK268788A - (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater - Google Patents

(e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater

Info

Publication number
DK268788A
DK268788A DK268788A DK268788A DK268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A
Authority
DK
Denmark
Prior art keywords
fluorphenyl
propenyl
piperazine
bis
phenyl
Prior art date
Application number
DK268788A
Other languages
Danish (da)
English (en)
Other versions
DK268788D0 (da
Inventor
Jean Mesens
Achiel Paul Van Peer
Jozef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK268788D0 publication Critical patent/DK268788D0/da
Publication of DK268788A publication Critical patent/DK268788A/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Pulmonology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fertilizers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK268788A 1987-05-18 1988-05-17 (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater DK268788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5064487A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
DK268788D0 DK268788D0 (da) 1988-05-17
DK268788A true DK268788A (da) 1988-11-19

Family

ID=21966482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK268788A DK268788A (da) 1987-05-18 1988-05-17 (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater

Country Status (19)

Country Link
EP (1) EP0292050B1 (ko)
JP (1) JPS63303926A (ko)
KR (1) KR880013559A (ko)
AT (1) ATE69555T1 (ko)
AU (1) AU603895B2 (ko)
DE (1) DE3866281D1 (ko)
DK (1) DK268788A (ko)
ES (1) ES2051827T3 (ko)
FI (1) FI882307A (ko)
GR (1) GR3003482T3 (ko)
HU (1) HU199073B (ko)
IE (1) IE60937B1 (ko)
IL (1) IL86395A (ko)
NO (1) NO882134L (ko)
NZ (1) NZ224497A (ko)
PH (1) PH24425A (ko)
PT (1) PT87496B (ko)
RU (1) RU1829935C (ko)
ZA (1) ZA883492B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002520A1 (en) * 1989-08-17 1991-03-07 Cortecs Limited Pharmaceutical formulations
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
US6596706B1 (en) * 1997-11-07 2003-07-22 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE60234952D1 (de) * 2001-09-10 2010-02-11 Tibotec Pharm Ltd VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
CN104069086A (zh) * 2014-07-22 2014-10-01 周有财 一种盐酸氟桂利嗪组合物胶囊及其制备方法
CN113262207B (zh) * 2020-02-17 2022-06-17 正大青春宝药业有限公司 一种盐酸氟桂利嗪胶囊制剂及其制备方法
CN115381791B (zh) * 2022-09-21 2023-06-16 迪沙药业集团有限公司 一种盐酸氟桂利嗪药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
DE3587978D1 (de) * 1984-01-28 1995-02-23 Roshdy Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs.
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
DK268788D0 (da) 1988-05-17
IL86395A0 (en) 1988-11-15
HU199073B (en) 1990-01-29
AU603895B2 (en) 1990-11-29
PT87496B (pt) 1992-09-30
EP0292050A1 (en) 1988-11-23
AU1613288A (en) 1988-11-24
NO882134D0 (no) 1988-05-16
ZA883492B (en) 1990-01-31
ATE69555T1 (de) 1991-12-15
NZ224497A (en) 1990-04-26
DE3866281D1 (de) 1992-01-02
HUT46851A (en) 1988-12-28
EP0292050B1 (en) 1991-11-21
NO882134L (no) 1988-11-21
IL86395A (en) 1992-11-15
ES2051827T3 (es) 1994-07-01
IE881477L (en) 1988-11-18
PT87496A (pt) 1989-05-31
FI882307A (fi) 1988-11-19
KR880013559A (ko) 1988-12-21
FI882307A0 (fi) 1988-05-17
IE60937B1 (en) 1994-09-07
GR3003482T3 (en) 1993-02-17
JPS63303926A (ja) 1988-12-12
RU1829935C (ru) 1993-07-23
PH24425A (en) 1990-06-25

Similar Documents

Publication Publication Date Title
DK268788A (da) (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater
BG28029A3 (en) Insecticide composition
ATE60878T1 (de) Verfahren fuer die herstellung von stabilen oeligen zusammensetzungen.
ATE147965T1 (de) Imidazol- und retinoidenthaltende hautpflegepräparate
DE69305328D1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
ATE150735T1 (de) Lagerstabil verkapseltes natriumpercarbonat und verfahren zu seiner herstellung
HUT49986A (en) Composition comprising alpha, omega-aminoalcohol derivative as active ingredient, for expelling insects and mites and process for producing new alpha, omega-aminoalcohol derivatives
ES2032818T3 (es) N-acil-n'-alquilocarbonilhidrazinas n'-sustituidas utiles como insecticidas.
FR2592409A1 (fr) Support de papier notamment pour le stockage de parfums.
IL79084A0 (en) E-isomers of n alpha-(2-cyano-2-alkoximinoacetyl)-amino acid derivatives and peptides,their preparation and their use as pesticides
ES8603240A1 (es) Un metodo para preparar una formulacion ectoparasiticida
KR850002377A (ko) 살충제 조성물
DE68918923D1 (de) Stabile Emulsionsformulierungen von wasserunlöslichen organischen Pestiziden.
IL72306A0 (en) 5-aminomethyl-1,3-oxathiolanes,their preparation and their use in combatting pests
KR880008795A (ko) 피부 화장료
DE69007956D1 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DK295789A (da) Stabil, vandig, primycinholdig suspoemulsion, dens fremstilling og anvendelse
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
ZA885227B (en) Injection containing 3-benzoyloxy-1,3,5(10)-estratriene-17-(4-(p-(bis(2-chloroethyl)amino)phenyl)-butanoyloxy)acetate as an active ingredient
DE3778826D1 (de) Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung.
BG31364A3 (en) Fungicide means and method for fungis
ES2058204T3 (es) Piridinas 3-substituidas y fungicidas que las contienen.
BG28979A3 (bg) Инсектицидно средство
FR2597480B1 (fr) Derives d'esters phosphoriques et compositions insecticides et acaricides contenant ces derives.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment